ArticleThe Journal of infection2021
High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in-hospital workers - The CoV-CONTACT cohort.
Registry-linked trialAbstract readLetterComment
In one paragraph
Article in The Journal of infection, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04259892 (Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection), which is not on this map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection
Who cites it
3 citing papers in PubMed.
- Serological response after SARS-CoV2 vaccination in healthcare workers: a multicenter study.La Medicina del lavoro · 2022Article
- Success of prophylactic antiviral therapy for SARS-CoV-2: Predicted critical efficacies and impact of different drug-specific mechanisms of action.PLoS computational biology · 2021Article
- High seroprevalence but short-lived immune response to SARS-CoV-2 infection in Paris.European journal of immunology · 2021Article
Corrections and comments
- Comment on
- Comment on
Authors and funding
26 authors.
Sarah TubianaAP-HP, Hôpital Bichat, Centre d'Investigation Clinique, Inserm CIC 1425, F-75018 Paris, France; Université de Paris, IAME, INSERM, F-75018 Paris, France; AP-HP, Hôpital Bichat, Centre de Ressources Biologiques, F-75018 Paris, France.
Charles BurdetAP-HP, Hôpital Bichat, Centre d'Investigation Clinique, Inserm CIC 1425, F-75018 Paris, France; Université de Paris, IAME, INSERM, F-75018 Paris, France; AP-HP, Hôpital Bichat, Département d'Epidémiologie, Biostatistique et Recherche, F-75018 Paris, France.
Nadhira HouhouAP-HP, Hôpital Bichat, Laboratoire de Virologie, F-75018 Paris, France.
Michael ThyAP-HP, Hôpital Bichat, Centre d'Investigation Clinique, Inserm CIC 1425, F-75018 Paris, France.
Pauline ManchonAP-HP, Hôpital Bichat, Centre d'Investigation Clinique, Inserm CIC 1425, F-75018 Paris, France; AP-HP, Hôpital Bichat, Département d'Epidémiologie, Biostatistique et Recherche, F-75018 Paris, France.
François BlanquartUniversité de Paris, IAME, INSERM, F-75018 Paris, France; Center for Interdisciplinary Research in Biology (CIRB), Collège de France, CNRS, INSERM, PSL Research University, Paris, France.
Charlotte CharpentierUniversité de Paris, IAME, INSERM, F-75018 Paris, France; AP-HP, Hôpital Bichat, Laboratoire de Virologie, F-75018 Paris, France.
Jérémie GuedjAP-HP, Hôpital Bichat, Centre d'Investigation Clinique, Inserm CIC 1425, F-75018 Paris, France; Université de Paris, IAME, INSERM, F-75018 Paris, France.
Loubna AlavoineAP-HP, Hôpital Bichat, Centre d'Investigation Clinique, Inserm CIC 1425, F-75018 Paris, France.
Sylvie BehillilMolecular Genetics of RNA Viruses, Department of Virology, CNRS UMR3569, Université de Paris, Institut Pasteur, Paris, France; National Reference Center for Respiratory Viruses, Institut Pasteur, Paris, France.
Anne LeclercqAP-HP, Beaujon Hospital, Direction des soins, F-92118 Clichy, France.
Jean-Christophe LucetUniversité de Paris, IAME, INSERM, F-75018 Paris, France; AP-HP, Hôpital Bichat, Equipe de Prévention du Risque Infectieux, F-75018 Paris, France.
Yazdan YazdanpanahUniversité de Paris, IAME, INSERM, F-75018 Paris, France; AP-HP, Hôpital Bichat, Service de Maladies Infectieuses et tropicales, F-75018 Paris, France.
Mikaël AttiaPhysique des fonctions biologiques, CNRS UMR3738, Institut Pasteur, Paris, France.
Caroline DemeretMolecular Genetics of RNA Viruses, Department of Virology, CNRS UMR3569, Université de Paris, Institut Pasteur, Paris, France.
Thierry RoseBiologie cellulaire des lymphocytes, INSERM - U1221, Department of Immunology, Institut Pasteur, Paris, France.
Julia Anna BielickiPaediatric Infectious Diseases Research Group, Institute for Infection and Immunity, St George's University of London, London SW17 0RE, United Kingdom; Paediatric Pharmacology and Paediatric Infectious Diseases, University of Basel Children's Hospital, Basel, Switzerland.
Patricia Bruijning-VerhagenJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands.
Herman GoossensLaboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, Faculty of Medicine and Health Science, University of Antwerp, Antwerp, Belgium.
Diane DescampsUniversité de Paris, IAME, INSERM, F-75018 Paris, France; AP-HP, Hôpital Bichat, Laboratoire de Virologie, F-75018 Paris, France.
Sylvie van der WerfMolecular Genetics of RNA Viruses, Department of Virology, CNRS UMR3569, Université de Paris, Institut Pasteur, Paris, France; National Reference Center for Respiratory Viruses, Institut Pasteur, Paris, France.
Bruno LinaCIRI, Centre International de Recherche en Infectiologie, (Team VirPath), Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007, Lyon, France; Laboratoire de Virologie, Centre National de Référence des Virus des infections respiratoires (dont la grippe), Institut des Agents Infectieux, Groupement Hospitalier Nord, Hospices Civils de Lyon, 69004, Lyon, France.
Xavier DuvalAP-HP, Hôpital Bichat, Centre d'Investigation Clinique, Inserm CIC 1425, F-75018 Paris, France; Université de Paris, IAME, INSERM, F-75018 Paris, France. Electronic address: xavier.duval@aphp.fr.
CoVCONTACT study group
Principal investigator
Sponsor: Inserm
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
COVID-19Personal Protective EquipmentHealth PersonnelHospitalsHumansInfectious Disease Transmission, Patient-to-ProfessionalSARS-CoV-2High-risk exposureIn-hospital workersPersonal protective equipmentSars-cov-2Transmission
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
NCT04259892ClinicalTrials.gov
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.